Repository of Research and Investigative Information
Baqiyatallah University of Medical Sciences
  |
 | Up a level |
(2021) Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations. Inform Med Unlocked. p. 100541. ISSN 2352-9148 (Print) 2352-9148